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DObjective: Functional ischemic mitral regurgitation (FIMR) increases mortality independently of the baseline
characteristics and ventricular function. The effect of treating FIMR with annuloplasty is unclear when mitral
regurgitation is moderate. Myocardial revascularization alone has been shown to improve mitral valve function.
Methods:We randomized 31 patients with moderate (grade 2-4) FIMR to receive either coronary artery bypass
grafting (CABG) alone or CABG plus downsizing mitral ring annuloplasty. The patients were followed up for
clinical outcomes and echocardiographic assessment of mitral valve function and left ventricular dimensions at
3 and 12 months. Clinical improvement was assessed using the Minnesota quality-of-life questionnaire,
6-minute walk test, and brain natriuretic peptide levels.
Results: The clinical course was similar in the 2 groups of patients during the study period. FIMR was perfectly
corrected intraoperatively in the ring group. Echocardiographic follow-up at 3 months showed no difference in
the FIMR grade between the 2 groups (66% less than grade 2 in the CABG alone and 86% in the CABG
plus ring group; P ¼ .316). The improvement in the CABG alone group was even more marked at 12 months
(85% less than grade 2 in the CABG group and 85% in the CABG plus ring group). The left ventricular ejection
fraction was significantly better at 3 months in the CABG alone group, although at 12months, the left ventricular
ejection fraction in the 2 groups had improved similarly.
Conclusions: Although initially effective at reducing moderate FIMR, the addition of a ring did not change the
clinical course after CABG surgery. At 12 months, no echocardiographic difference was found in terms of re-
sidual mitral regurgitation, left ventricular dimensions and function, or clinical outcomes. (J Thorac Cardiovasc
Surg 2014;147:1471-7)Earn CME credits at
http://jtcvs.com/cme/home
Functional ischemic mitral regurgitation (FIMR) increases
mortality independently of the baseline characteristics and
ventricular function and is directly related to the degree of
FIMR.1Many surgeons address FIMR at surgical revascular-
ization, because some clinical studies have not supported cor-
onary artery bypass grafting (CABG) as an effective
treatment of FIMR.2 Downsizing ring annuloplasty (ring)
as an adjunct procedure to CABG has been used to correct
Carpentier type I and type IIIB dysfunction in patients with
FIMR, with a high freedom rate from intraoperative mitral
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The Journal of Thoracic and Carinvestigators have reported excellent long-term results,3,4
although others have reported an exponentially increasing
rate of recurrent FIMR up to approximately 70% at
5 years.4-6 The effect of adding downsizing ring
annuloplasty to CABG in patients with ischemic mitral
regurgitation has been thoroughly addressed in published
studies. A recent meta-analysis of a nonrandomized series7
and 2 randomized studies8,9 comparing CABG and CABG
combined with downsizing ring annuloplasty showed that
the addition of a ring resulted in a lower mitral
regurgitation grade and New York Heart Association
(NYHA) class compared with CABG alone but did not
improve the survival rate. The present study reports the
results of a randomized trial focusing on the clinical
and echocardiographic outcomes throughout 1 year after
surgery.
METHODS
Study Population
From 2002 to 2008, 67 patients with coronary artery disease and FIMR
were referred for cardiac surgery at the Montreal Heart Institute and were
screened for randomization. The inclusion criteria were grade 2þ FIMR
with a concomitant need for CABG. The exclusion criteria were papillary
muscle rupture, a concomitant need for aortic valve surgery, life expec-
tancy less than 12 months from noncardiac causes, creatinine >200
mmol/L, and more than grade 2 FIMR. A total of 31 patients were included
in the study and randomized to CABG alone (n ¼ 16) or CABG combined
with ring annuloplasty (n¼ 15). All the patients provided written informeddiovascular Surgery c Volume 147, Number 5 1471
Abbreviations and Acronyms
BNP ¼ brain natriuretic peptide
CABG ¼ coronary artery bypass grafting
ERO ¼ effective regurgitation orifice
FIMR ¼ functional ischemic mitral regurgitation
QOL ¼ quality of life
LA ¼ left atrial
LV ¼ left ventricular
LVEF ¼ LV ejection fraction
MR ¼ mitral regurgitation
NYHA ¼ New York Heart Association
OR ¼ operating room
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Dconsent, and the local ethics committee approved the study. All authors had
full access to, and take full responsibility for, the integrity of the data.
Operative Technique
All surgical procedures were performed through a midline sternotomy.
Mild hypothermic cardiopulmonary bypass and cold blood cardioplegia
were used. The left internal mammary artery was grafted to the left anterior
descending coronary artery in all patients. The remaining revascularization
was done using saphenous vein grafts. In the CABG group, 2 patients
underwent surgery with an off-pump beating heart technique. In the
CABG plus ring group, rigid ring annuloplasty was performed (size
26-28), downsized by 2 sizes according to the anterior leaflet height and
intercommissural distance. Three patients received a Carpentier Edwards
ETlogix ring (Edwards Lifesciences, Irvine, Calif), and 12 patients
received a Carbomedics Annuloflo ring (Sorin, Milano, Italy).
Echocardiography
Serial transthoracic echocardiographic studieswereperformedpre-, intra,
and postoperatively at 3 and 12 months. The left ventricular (LV) M-mode
spectrumwas obtained in the parasternal long-axis view; the LV dimensions
at both end cardiac diastole (LVDd) and systole (LVDs) were measured. LV
fractional shortening was calculated as (LVDd  LVDs)/LVDd 3 100%.
Apical 4-chamber and 2-chamber views were recorded. The Simpson
methodwas used to calculate the end-systolic and end-diastolic LV volumes
(LVVd, LVVs). TheLVejection fraction (LVEF)was calculated as (LVVd
LVVs)/LVVd 3 100%. Mitral regurgitation (MR) was quantified by
measurements of the MR jet area and left atrial (LA) area using color
mapping of the apical 4-chamber view during cardiac systole. MR was
semiquantitatively graded using the jet area/LA area 3 100%, with grade
I representing<20%; grade II, 20-40%; and grade III-IV, 40%. The
effective regurgitation orifice (ERO) area, MR volume, and regurgitation
fraction were calculated using the proximal isovelocity surface area or Dop-
pler method, as previously described.10,11 MR was further quantitatively
graded as I, II, III, IV, with an ERO of<20, 20-29, 30-39, and 40 mm2,
regurgitant volume of<30, 30-44, 45-59, and 60 mL, and regurgitation
fraction of<30, 30-39, 40-49, and 50%, respectively.
Clinical Follow-up
The patients completed the Minnesota quality of life (QOL) question-
naire12 at 3 months. The French version of this questionnaire was tested
for validity and reliability.13 Cronbach’s alpha ranged from 0.73 to 0.93,
except for its incapacity dimension (0.40). The intraclass correlation coef-
ficients were all greater than 0.70 in the 4 dimensions of the questionnaire.
These results were similar to those obtained with the original question-
naire.12 The patients also performed a 6-minute walk test and underwent
brain natriuretic peptide (BNP) measurements. BNP measurements were1472 The Journal of Thoracic and Cardiovascular Surtaken and the QOL questionnaire was completed preoperatively and at
the 3- and 12-month follow-up examinations conducted by physicians at
the Montreal Heart Institute Valve Clinic.
Study Endpoints
The primary endpoint was the LV dimension changes at 1 year. The
secondary endpoints were difference in the BNP levels, QOL score, and
6-minute walk test results at 3 months, and the NYHA class and MR grade
at 3 months and 1 year.
The randomization took place in the operating room (OR), after the skin
incision. The patients were unaware of the mitral correction status for the
first year after their surgery. The surgeons and cardiology teams treating
the patient and the echocardiographers analyzing the images were aware
of the correction status.
Statistical Analysis
Continuous data are presented as themean standard deviation, and the
categorical data are presented as numbers (percentages).
Between the groups, comparisons were performed using Student t tests
and Pearson’s chi-square tests for continuous and categorical variables, re-
spectively. For continuous variables with preoperative measures, the post-
operative values were compared between groups using analyses of
covariance to reduce the error mean squares.
Within group comparisons were performed using paired t tests and the
McNemar-Bowker chi-square test for continuous and categorical variables,
respectively.
Usual assumptions such as normality and homoscedasticity of the
variance were verified. Transformations and/or more robust procedures
such as nonparametric tests were used when necessary. Parallelism of
the regression lines (or interaction) was verified when using analyses of
covariance, but no interaction was detected. The level of significance
was set at .05 for all procedures. Because of the small sample sizes,
adjustments for multiplicity of testing were not used. All analyses were
performed using the Statistical Package for Social Sciences, version 20
(SPSS, Inc, Chicago, Ill).
RESULTS
Patient Population and Perioperative Outcomes
Table 1 lists the baseline characteristics of the 2 groups,
and the operative procedure details are listed in Table 2.
No significant difference was found in the preoperative
patient characteristics between the 2 groups. As expected,
the group randomized to CABG plus ring had longer
crossclamp and cardiopulmonary bypass times.
Clinical Follow-up
Postoperative versus preoperative. The clinical follow-
up data are listed in Table 3. In both groups, the NYHA class
had improved at 3 and at 12 months compared with preop-
eratively. The percentage of patients in NYHA class III and
IV decreased from 50% at the preoperative evaluation to
17% and 0% at 3 and 12 months, respectively, for the
CABG group and from 40% preoperatively to 0% and
8% for the CABG plus ring group. However, owing to small
samples, these important decreases were not statistically
analyzable using the McNemar-Bowker chi-square test.
No statistically significant improvement in QOL was
observed at 3 months of follow-up in either group
(CABG, P ¼ .276; CABG plus ring, P ¼ .131). A trend
was seen toward a reduction in BNP at 3 months in thegery c May 2014
TABLE 1. Patient characteristics
Characteristic
CABG
(n ¼ 16)
CABG plus
ring (n ¼ 15) P value
Male gender 14 (88) 12 (75) .585
Smoking (yes) 5 (31) 5 (33) .905
Diabetes (yes) 8 (50) 4 (27) .195
Dyslipidemia (yes) 12 (75) 10 (67) .624
Hypertension (yes) 9 (56) 11 (73) .337
COPD (yes) 3 (19) 4 (27) .613
Preoperative atrial fibrillation 2 (13) 3 (20) .570
Previous AMI (yes) 12 (75) 9 (60) .389
Creatinine (mmol/L) 93  28 105  24 .231
Age (y) 65  12 69  7 .290
BMI (kg/m2) 27  4 27  5 .942
Data are presented as n (%) or mean  standard deviation. CABG, Coronary artery
bypass grafting; ring, downsizing mitral ring annuloplasty; COPD, chronic obstruc-
tive pulmonary disease; AMI, acute myocardial infarction; BMI, body mass index.
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the CABG patients (P ¼ .317).
CABG versus CABG plus ring. In the CABG group, 1
patient died at 2 months postoperatively, but no new deaths
had occurred at 1 year. In the CABG plus ring group, 1 pa-
tient died on postoperative day 1 of bleeding and
tamponade, with no deaths afterward. All patients were in
sinus rhythm preoperatively and at 3 and 12 months of
follow-up. One patient in the CABG plus ring group
required an implantable automatic cardioverter defibrillator
preoperatively; no other pacemakers were implanted postop-
eratively. A significant difference was seen in the NYHA
class at 3 months (P¼ .052), with more CABG-only patients
returning toNYHAclass I (Table 3). At 1 year, this difference
had decreased to a nonsignificant level (P ¼ .122). The
changes in NYHA class from preoperatively to 3 months,
from preoperatively to 12 months, and from 3 months to 12
months were compared between the 2 groups (Table 3).
The Canadian Cardiovascular Society classes were similar
at 3 and 12 months (P ¼ .651 at 3 and 12 months). The
6-minute walk test results at 3 months were similar
(P ¼ .415). The Minnesota QOL score and BNP blood level
were also similar at 3 months (P ¼ .490 and P ¼ .766,
respectively). One early stroke occurred in the ring group
and none in the CABG-only group. One readmission wasTABLE 2. Perioperative characteristics
Characteristic
CABG
(n ¼ 16)
CABG plus
ring (n ¼ 15) P value
LIMA to LAD 16 (100) 15 (100) 1.000
Clamp time (min) 63  29 94  28 .008
ECC (min) 89  31 116  37 .046
CK-MB day 1 (IU/L) 21  30 24  10 .779
Data are presented as n (%) or mean  standard deviation. LIMA, Left internal
mammary artery; LAD, left anterior descending coronary artery; ECC, extracorporeal
circulation; CKMB, creatine kinase-myocardial band isoenzyme; CABG, coronary
artery bypass grafting; ring, downsizing mitral ring annuloplasty.
The Journal of Thoracic and Carnecessary in each group at 1 year. The need for oral warfarin
therapy was similar in the 2 groups (P ¼ .116).
Echocardiographic Results
Postoperatively versus preoperatively. The MR grades
measured intraoperatively and at 3 and 12 months of
follow-up are listed in Table 4. In the CABG plus ring
group, the intraoperative results were near-perfect, with
93% having MR grade 0. At 3 months, some grade II MR
had appeared (14%), with a significant number of patients
in grade I (43%). The echocardiographic grades were
slightly greater at 1 year, with 7% in grade II and III. In
the CABG-only group, the pattern of MR differed, with
most patients still having grade II MR intraoperatively,
decreasing to grade I or less in 66% by 3 months and
85% at 1 year. Considering the echocardiographic results
at 3 and 12 months of follow-up more precisely, in both
groups, the MR parameters and LV dimensions showed an
overall pattern of reduction compared with preoperatively
(Table 5). Specifically, for the CABG group, a significant
reduction was seen in the ERO, jet area, jet area/LA area,
regurgitant volume, regurgitant fraction, LV end-diastolic
diameter, and LVend-systolic diameter at 3 and 12 months.
Furthermore in the CABG group, fractional shortening had
improved significantly at 3 months, and the LVEF had done
so at 12 months. For the CABG plus ring group, a similar
decrease in the ERO, jet area, jet area/LA area, regurgitant
volume, and regurgitant fraction was noted. However, no
significant improvements were noted in the repair group
regarding the LV dimensions and volumes or fractional
shortening and LVEF at the 2 follow-up points.
CABG versus CABG plus ring. No preoperative signifi-
cant differences were found in the various echocardio-
graphic measurements.
Immediately after surgery, the residual MR was mark-
edly less in the ring group (93% with no MR at all)
compared with the CABG-only group, in which only
13% had improved to grade I (P ¼ .000; Table 4). This
difference was no longer significant at 3 (P ¼ .25) or 12
(P ¼ .72) months. To better understand how the MR grade
changed at the different echocardiographic examinations
between the 2 groups, we compared the difference in MR
grade at the 3 measurement points. The changes occurring
between the day of surgery (DOS) transesophageal echocar-
diogram and the 3-month echocardiogram, between the
DOS and 12-month echocardiograms, and the 3-month
and 12-month echocardiograms were compared (Table 6).
For the DOS–3-month comparison, 67% of the CABG
group had improved by 1 or 2 grades, 22% remained
identical, and 11% had worsened. In the CABG plus ring
group, no patient had improved their MR grade (the surgical
procedure completely corrected the MR in the OR room),
although 54% had some recurrence and the MR had
worsened by 1 or 2 grades (P ¼ .016).diovascular Surgery c Volume 147, Number 5 1473
TABLE 3. Clinical follow-up
Variable
Preoperative 3 mo 1 y
CABG CABG plus ring CABG CABG plus ring CABG CABG plus ring
Deaths (n) 0 0 1 (6) 1 (7) 0 0
NYHA class (%)
I 10 0 75 46 100 77
II 40 60 8 54 0 15
III-IV 50 40 17 0 0 8
CCS class
0-I 100 92 100 100
II-IV 0 8 0 0
Stroke 0 (0) 1 (8) 0 (0) 0 (0)
Cardiac hospitalization 1 (11) 1 (8)
OAT 1 (11) 5 (38)
6-min Walk test (m) 409  90 383  63
QOL score 28  26 33  25 15  12 19  15
BNP (pg/mL) 1911  3174 1743  1361 926  951 671  670
Data are presented as n (%), percentages, or mean standard deviation. NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; OAT, oral anticoagulation
therapy; QOL, Minnesota quality of life questionnaire; BNP, brain natriuretic peptide; CABG, coronary artery bypass grafting; ring, downsizing mitral ring annuloplasty.
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ring the OR echocardiographic values to those at 12months.
In the CABG group, the MR grade had improved in 77%,
was stable in 15%, and had worsened in 8%. In the
CABG plus ring patients, the MR grade had worsened in
69% (P ¼ .004). The differences in the echocardiographic
changes from 3 to 12 months were not statistically signifi-
cant between the 2 groups (P ¼ .13).
All continuous echocardiographic parameters were com-
pared at 3 and 12 months, adjusting for the preoperative
values. The 3- and 12-month adjusted values are listed on
Table 7. The only statistically significant difference was
better LVEF at 3 months in the CABG-only group: 49%
 3% for the CABG group compared with 42%  2%
for the CABG plus ring group (P ¼ .045). This difference
had disappeared at 1 year, and in both groups the LVEF
had improved to comparable levels (CABG 52%  2%
and CABG plus ring 48%  2%; (P ¼ .204)).
DISCUSSION
A total of 31 patients with moderate ischemic MR were
randomized to CABG alone or CABG plus a downsized
mitral ring. The major findings of the present study were,
first, that combining a downsized mitral annuloplasty ring
with CABG successfully eliminated MR immediately inTABLE 4. Mitral regurgitation grade preoperatively, intraoperatively, an
MR grade
Preoperatively (%) Intraoperatively (%)
CABG
(n ¼ 16)
CABG plus
ring (n ¼ 15)
CABG
(n ¼ 16)
CABG pl
ring (n ¼
0 0 0 0 93
1 0 0 13 7
2 100 100 87 0
3 0 0 0 0
MR, Mitral regurgitation; CABG, coronary artery bypass grafting; ring, downsizing mitra
1474 The Journal of Thoracic and Cardiovascular Surthe OR, although CABG alone did not. Second, at 3 and
12 months of follow-up, no significant difference was found
in the residual MR grade between the 2 groups. At the
3-month echocardiogram, the MR had started improving
in the CABG-only group (with 44% of patients improving
by 1 and 22% by 2 grades). During the same period, the
patients in the CABG plus ring group had developed
recurrent MR by 1 grade in 46% and 2 grades in 8%.
This phenomenon of delayed improvement after CABG
and delayed recurrence after annuloplasty was even more
evident on the 12-month echocardiogram. Third, the
ERO, jet area, jet area/LA area, regurgitant volume, and
regurgitant fraction were all decreased by the same
magnitude 1 year after surgery, with no better results
conferred by the presence of the restrictive annuloplasty.
Similarly, the LV systolic and diastolic dimensions were
improved in both groups, with no intergroup difference
found. Finally, although for the CABG group, fractional
shortening showed some early improvement at 3 months
(P ¼ .060) and the LVEF had improved significantly at
12 months (P ¼ .040), no improvement was seen in the
contractile function of the left ventricle in the CABG plus
ring group. When performing group comparisons adjusted
for the preoperative level, the LVEF was significantly better
at 3 months in the CABG-only group. Adaptation to thed 3 months and 1 year postoperatively
3 mo (%) 12 mo (%)
us
15)
CABG
(n ¼ 14)
CABG plus
ring (n ¼ 14)
CABG
(n ¼ 14)
CABG plus
ring (n ¼ 13)
22 43 21 23
44 43 64 62
33 14 14 7
0 0 0 7
l ring annuloplasty.
gery c May 2014
TABLE 5. Echocardiographic parameters preoperatively and 3 and 12 months postoperatively and comparisons within each group
Variable
Preoperatively 3 mo 12 mo
CABG
(n ¼ 16)
CABG plus
ring (n ¼ 15)
CABG
(n ¼ 14)
CABG plus
ring (n ¼ 14)
CABG
(n ¼ 14)
CABG plus
ring (n ¼ 13)
ERO (mm2) 22.7  5.2 19.5  3.2 6.7  7.6 (.004) 5.9  7.6 (.020) 4.5  7.2 (.000) 8.9  11.2 (.277)
Jet area (cm2) 7.5  4.0 7.8  3.4 4.1  3.8 (.006) 3.7  4.3 (.027) 3.4  3.8 (.013) 3.8  3.3 (.002)
LA area (cm2) 21.1  7.2 19.9  7.2 23.8  8.4 (.391) 21.1  8.7 (.115) 18.7  10.0 (.248) 22.2  5.7 (.895)
Jet area/LA area (%) 34.1  7.0 39.0  5.9 15.8  11.4 (.002) 16.5  16.1 (.008) 16.6  12.6 (.008) 16.4  13.5 (.012)
RV (mL) 36.9  8.6 35.0  10.7 10.6  11.7 (.000) 12.0  15.3 (.005) 6.7  9.8 (.000) 13.5  16.9 (.060)
RF (%) 21.9  10.0 25.0  11.7 7.0  8.1 (.010) 9.1  10.1 (.019) 4.0  5.5 (.008) 8.1  10.4 (.168)
LVEDD (cm) 5.9  0.8 5.4  0.7 5.6  0.7 (.050) 5.1  0.9 (.149) 5.5  0.7 (.003) 5.3  0.7 (.339)
LVESD (cm) 4.4  0.9 4.0  0.8 3.8  1.0 (.012) 3.8  1.0 (.763) 3.9  1.0 (.057) 3.8  1.0 (.344)
LVEDV (mL) 118.4  40.3 133.9  35.1 97.2  31.5 (.129) 104.4  31.9 (.076) 118.8  52.2 (.050) 119.2  48.9 (.071)
LVESV (mL) 57.4  30.2 76.6  30.1 38.6  9.6 (.159) 53.6  23.4 (.066) 58.4  41.2 (.224) 62.0  30.2 (.066)
FS (%) 25.7  10.7 28.6  10.6 32.1  12.0 (.060) 28.3  13.3 (.914) 29.2  9.1 (.333) 30.4  9.7 (.918)
LVEF (%) 41.5  17.4 45.7  11.4 45.8  20.2 (.112) 43.3  12.9 (.237) 51.4  13.3 (.040) 48.4  6.7 (.181)
Data are presented as mean  standard deviation, with P values in parentheses (P values represent t test comparison for preoperatively versus postoperatively). ERO, Effective
orifice area; LA, left atrium; RV, regurgitant volume; RF, regurgitant fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter;
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; FS, fractional shortening; LVEF, left ventricular ejection fraction; CABG, coronary
artery bypass grafting; ring, downsizing mitral ring annuloplasty.
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petency could explain the absence of LVEF improvement
after annuloplasty. As the ventricle adapts and the volume
overload recedes, LV function will start to improve by 1
year.14 The effect of adding mitral annuloplasty to CABG
was assessed using important clinical parameters, such as
NYHA class, Canadian Cardiovascular Society class,
BNP level, and QOL scores. The NYHA functional class
improved in both groups; however, this clinical improve-
ment was statistically more important for the CABG-only
group at 3 months, a possible consequence of the observed
decline in LVEF in the CABG plus ring patients at the same
point. At 1 year, both groups had improved their NYHA
class and LVEF equally. The heart failure status was also as-
sessed using the Minnesota QOL score and BNP measure-
ments. These assessments were not discriminatory of
better improvement with either operative strategy. The
addition of downsized ring annuloplasty to CABG only
transiently reduced the MR, and, at 3 months, the patients
with the annuloplasty ring seemed to do worse than the
patients with CABG alone. Their LV function was
depressed and their functional class improvement lagged
behind that of the CABG-only group. By 1 year, the func-
tional improvements and echocardiographic values regard-
ing LV function and mitral valve function were identical.TABLE 6. Delta-MR grade comparisons between both groups
Group
From OR to 3 mo (%) Fro
Worse Unchanged Better Worse
CABG 11 22 67 8
CABG plus ring 54 46 0 69
P value .016
OR, Operating room; CABG, coronary artery bypass grafting; ring, downsizing mitral rin
The Journal of Thoracic and CarThe comparison of CABG with and without mitral valve
surgery was assessed by a meta-analysis of 9 retrospective
studies, including a total of 2479 patients with FIMR grade
2.2 to 3.9 undergoing CABG (n ¼ 1515) or CABG
combined with mitral valve surgery (n ¼ 964).7 In that
study, no benefit for long-term survival was observed;
however, mitral valve surgery did reduce the MR grade
more than did CABG-only surgery. NYHA class improve-
ment could not be demonstrated statistically in this large
meta-analysis. In 2009, Fattouch et al8 published the first
randomized study comparing CABG alone and CABG
plus ring for grade 2 FIMR. That study was recently
followed by another multicenter study by Chan et al.9 In
the study by Fattouch et al,8 a residual MR grade of only
0.8 after CABG plus ring compared with 1.7 in the
CABG group was observed at a mean follow-up of 32
months. Furthermore, the LV dimensions and NYHA class
had also improved compared with CABG alone, although
no difference in 5-year mortality was observed.8 The study
by Chan et al,9 although aiming to measure the difference in
peak oxygen consumption, LV remodeling, and MR
severity, did not succeed in showing improved survival
and found a worse postoperative course after repair in
terms of transfusion, intubation time, and operative time.
Despite very similar patient characteristics and operativem OR to 12 mo (%) From 3 mo to 12 mo (%)
Unchanged Better Worse Unchanged Better
15 77 14 57 29
31 0 33 67 0
.004 .129
g annuloplasty.
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TABLE 7. Postoperative echocardiographic parameters adjusted for preoperative level and between group comparisons at 3 and 12 months
Variable
3 mo 12 mo
CABG (n ¼ 14) CABG plus ring (n ¼ 14) P value CABG (n ¼ 14) CABG plus ring (n ¼ 13) P value
ERO (mm2) 7  4 4  4 .679 4  5 9  6 .553
Jet area (cm2) 3.8  1.5 3.5  1.4 .882 3.4  1.1 3.1  1.1 .834
LA area (cm2) 23  2 22  2 .673 18  3 22  3 .397
Jet area/LA area (%) 16  6 15  6 .904 16  5 164  6 .860
RV (mL) 10  5 10  5 .970 7  6 11  7 .648
RF (%) 6.8  3.6 8.1  3.3 .798 4.1  3.6 9.0  4.5 .419
LVEDD (cm) 5.3  0.2 5.3  0.1 .855 5.3  0.1 5.4  0.1 .503
LVESD (cm) 3.5  0.2 4.1  0.2 .081 3.7  0.2 4.0  0.2 .475
LVEDV (ml) 97  11 111  9 .344 112  6 110  6 .869
LVESV (ml) 42  8 55  7 .245 50  6 58  6 .427
FS (%) 33  4 26  4 .315 30  4 28  4 .660
LVEF (%) 49  3 42  2 .045 52  2 48  2 .204
CABG, Coronary artery bypass grafting; ring, downsizing mitral ring annuloplasty; ERO, effective orifice area; LA, left atrium; RV, regurgitant volume; RF, regurgitant fraction;
LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic
volume; FS, fractional shortening; LVEF, left ventricular ejection fraction.
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study, in which we observed a lower residual MR grade in
the CABG group and a higher residual MR grade in the
CABG plus ring group. No explanation is obvious why
CABGwas more efficient and CABG plus ring less efficient
in our study at relieving MR. Although not part of the
protocol, 6 of 16 patients randomized to the CABG group
had undergone preoperative viability studies, with only 2
of these studies suggesting some inferior wall viability.
The large-scale National Institutes of Health–Canadian
Institutes of Health Research-sponsored randomized study
underway in North America should shed additional light
on this issue.
Before making final conclusions about whether to add
mitral annuloplasty to CABG, the technique should be
performed rigorously. Recurrent MR does occur after
CABG plus ring, even if only in a subgroup of patients
prone to failure. The predictive values of mitral annulo-
plasty failure were suggested by Braun et al,3 who identified
enlarged left ventricles> 65 mm, Calafiore et al,15 who
identified a coaptation depth> 10 mm, and Magne et al,5
who identified a posterior leaflet angle of 45 as cutoff
values to opt for valve replacement instead of repair.
However, a subvalvular approach to improve repair durabil-
ity has been suggested as an alternative solution to preserve
the native valve. A key factor in the pathogenesis of
ischemic MR is papillary muscle displacement away from
the anterior annulus, causing mitral leaflet tethering and
type IIIb leaflet dysfunction. It is important to realize that
downsized ring annuloplasty only addresses Carpentier
type I valve dysfunction caused by annular dilatation but
does not correct apical tethering and might, in fact, even
further increase leaflet tethering.16,17 In an effort to
address the papillary muscle displacement and correct
Carpentier type IIIb dysfunction, Kron et al18 introduced
papillary muscle relocation in 2002, and in 2009, Langer1476 The Journal of Thoracic and Cardiovascular Suret al19 published a series of a modified papillary muscle
relocation technique concomitantly with CABG plus ring,
showing improved freedom from recurrent MR compared
with historical controls. Whether this will also be realized
in a randomized setting remains to be seen.
The small sample size of the present study could have
limited our power to detect important changes for some of
the clinical or echocardiographic findings. First, recruit-
ment was very difficult (50% of the identified patients
refused participation in the study). The present study was,
in fact, terminated when the Montreal Heart Institute joined
the National Institutes of Health–Canadian Institutes of
Health Research project on moderate MR (CABG versus
CABG with downsized ring annuloplasty). Those consider-
ations taken into account, addressing moderate FIMR with
CABG alone seems to be a simpler procedure with equally
good clinical and echocardiographic improvement at 1 year.
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